Caladrius Biosciences is currently followed by the analysts listed below. This list is subject to change as firms add or delete coverage of the company. Please note that any opinions, estimates or forecasts regarding Caladrius’ performance made by analysts are theirs alone and do not represent the opinions, forecasts or predictions of Caladrius or its management. Caladrius is providing this list as a service to its shareowners, and does not by listing these firms imply its endorsement of or concurrence with their information, conclusions or recommendations.
|Aegis Capital||Robert LeBoyer|
|Chardan Securities||Keay Nakae|
|H.C. Wainwright & Co.||Yi Chen & Raghuram Selvaraju|
|WBB Securities||Steve Brozak|